Firstly, using a bidirectional MR analysis, we found that the genetically predicted circulating levels of CX3CL1, GDNF, IL-2RB, LAP TGF-beta-1, LIF-R, and TRAIL were associated with CRC risk. This evidence concerns the gene TGFB1 and colorectal carcinoma.